TherapeuticsMD Inc

NASDAQ:TXMD   3:59:58 PM EDT
0.28
-0.01 (-2.50%)
Products

U.S. Food And Drug Administration (FDA) Responds To Request From Therapeuticsmd To Revise Certain Manufacturing Testing Limits For Annovera

Published: 12/10/2021 21:37 GMT
TherapeuticsMD Inc (TXMD) - U.S. Food and Drug Administration (fda) Responds to Request From Therapeuticsmd to Revise Certain Manufacturing Testing Limits for Annovera®.
Therapeuticsmd Inc - FDA Determined That It Could Not Approve Proposed Revisions to Manufacturing Testing Limits Requested Through Snda.
Therapeuticsmd Inc - FDA Provided Recommendations and Requested Additional Information to Address Issues.
Therapeuticsmd Inc - Will Continue to Supply Annovera in Compliance With Manufacturing Testing Limits Approved in Original NDA.
Therapeuticsmd Inc - Submitted Proposed Revisions to Manufacturing Testing Limits.